Skip to main content

Next-Generation Vaccines Eradicating Chronic and Infectious Diseases


The growing prevalence of chronic and infectious disorders such as cancer, and diabetes, globally has emerged as the biggest concerns that the medical industry faces today. There have been continuous attempts to develop improved treatment procedures for such diseases.
Vaccines have been one of the most effective methods for the treatment and prevention of diseases. The invention of DNA, recombinant, and cancer vaccines, and advancements in the platform for vaccine delivery have transformed the conventional therapeutic and preventive vaccines and are playing an important role in the treatment of such chronic diseases.
At present, the vaccine market is in its growing stage, however as per the market intelligence report published by BIS Research titled “Global Vaccine Market – Analysis and Forecast (2018 – 2028),” the vaccine market is anticipated to witness tremendous growth at 11.0% during the forecast period, 2018 – 2028 and generate $103.57 billion in the revenue by 2028.
This high growth of the market can be attributed to the increasing incidences of chronic diseases, growing adoption of vaccines across developed as well as developing countries, and the invention of advanced techniques and technologies.  Amongst the long list of advantages of vaccines, the reduced healthcare cost and improved life expectancy rate are their major benefits.
Several leading pharmaceutical companies are venturing in the market, some of these include Abbott Laboratories, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Johnson & Johnson, Merck & Company Inc., and Madison Vaccines Incorporated.
The report published by BIS Research discusses the vaccine market under different segments on the basis of type, disease type, and region. Under the vaccine type, there are subunit and conjugate, live attenuated, inactivated, recombinant, toxoid, and next-generation vaccines. Moreover, the disease type segment includes cancer, hepatitis, rotavirus, varicella, and influenza, among others.
Under the region segment, the report analyzes the market for North America, Europe, Asia-Pacific, Latin America, and Middle East Africa. Amongst these, Asia-Pacific region is expected to grow at the fastest CAGR during the forecast period.
With technological advancements in the medical industry, vaccines for multiple cancers such as gastric, ovarian, melanoma, and prostate cancer have already been developed and several companies at present are focusing to develop next-generation vaccines. The global vaccine market in the coming years is expected to evolve and undergo various developments and advancements.

Comments

Post a Comment

Popular posts from this blog

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of  Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...
2 comments
Read more

Analyzing the Growth and Expansion of the Neurostimulation Devices Market

The global healthcare economic burden, at present, is primarily characterized by major contributors such as chronic pain and neurological disorders. The annual societal cost for chronic pain and neurological disorders accounted for $635 billion and $789 billion respectively in the U.S., in 2014. Opioids are one of the most preferred medicines for the treatment of chronic pain, however, the side-effects associated with opioids have resulted in a decline in their overall usage and sale. Consequently, the increasing cases of neurological disorders and the need for a novel approach for the treatment of such diseases has led to the advent of neuromodulation technologies. The rapid shift of the healthcare industry toward neurostimulation devices from opioids and other conventional treatment techniques can be attributed to the efficient, safe, and targeted approach of neurostimulation devices. BIS Research recently published a market intelligence report titled “ Global Neurostim...
Post a Comment
Read more

Tilt Rotor Aircraft Market Analysis & Forecast by 2031

The tilt rotor aircraft has been constantly evolving over the years, facing numerous technical difficulties, and had several accidents due to its complex structure and design; the latest technologies such as vectored thrust and ducted fans are being used widely to tackle this problem. Several companies have been trying to enter the market to leverage the market need and increase their market share at a global level by making strategic partnerships with key players and raising funds from venture capitalists. Several private start-ups such as Lilium GmbH, Joby Aviation, Kitty Hawk, Overair have already developed prototypes or are still in the research and development phase to use the advantages of tilt rotor technology for civilian applications such as urban air mobility, cargo, and logistics transportation, and others. Read Report Overview: https://bisresearch.com/industry-report/tilt-rotor-aircraft-market.html The tilt rotor aircraft are initially used in the military and d...
Post a Comment
Read more